22nd Century Group Sales Drop 49 Percent

22nd Century Group (NASDAQ:XXII), a tobacco harm reduction company developing and marketing very low nicotine content (VLNC) cigarettes under its VLN® brand, reported its second quarter 2025 financial results on August 14, 2025. The quarter saw GAAP revenue of $4.1 million fall well short of analyst expectations of $5.44 million, with actual GAAP revenue at $4.08 million versus the $5.44 million estimate. Compared to the prior year period, GAAP revenue declined by 48.6%. Gross profit was negative, and the operating loss increased to $3.0 million, compared to $2.6 million for Q1 2025. Despite these financial setbacks, the company advanced in distribution deals, continued cost reductions, and reduced debt. However, the lack of material VLN® sales in the quarter highlights the ongoing challenge of translating product milestones into commercial traction. Source: Analyst estimates for the quarter provided by FactSet. 22nd Century Group is a tobacco harm reduction company focused on developing and commercializing very low nicotine content (VLNC) cigarettes under the VLN® brand. Its proprietary plant genetics enable cigarettes that meet or fall under the U.S. Food and Drug Administration’s (FDA) proposed reduced nicotine standards. The company aims to give adult smokers options to control nicotine consumption in a market where regulatory and consumer health trends are shifting.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool